Mon, April 19, 2021
Fri, April 16, 2021
Thu, April 15, 2021
Wed, April 14, 2021
Tue, April 13, 2021
Mon, April 12, 2021

James Mainwaring Initiated (ABT) at Hold and Held Target at $122 on, Apr 15th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. old-and-held-target-at-122-on-apr-15th-2021.html
  Print publication without navigation Published in Stocks and Investing on by
          🞛 This publication is a summary or evaluation of another publication

James Mainwaring of Atlantic Equities, Initiated "Abbott Laboratories" (ABT) at Hold and Held Target at $122 on, Apr 15th, 2021.

James has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 1 agrees with James's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $115 on, Saturday, February 6th, 2021


These are the ratings of the 7 analyists that currently disagree with James


  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $130 on, Thursday, March 11th, 2021
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $136 on, Thursday, January 28th, 2021
  • Bob Hopkins of "B of A Securities" Maintained at Strong Buy with Increased Target to $145 on, Thursday, January 28th, 2021
  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Increased Target to $140 on, Thursday, January 28th, 2021
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $137 on, Thursday, January 28th, 2021
  • Marie Thibault of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $140 on, Thursday, January 28th, 2021
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Thursday, January 28th, 2021